Precision for Medicine
Precision for Medicine, Oncology and Rare Disease is the first comprehensive, fully-integrated CRO devoted to oncology and rare disease innovation. Precision provides full service, global support to life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively, and applies novel biomarker approaches to clinical research that take advantage of the latest advancements in science and technology. We focus predominantly on clinical trial excellence, with fully integrated genomics, immune-response assays, global specimen logistics, biomarker analytics and companion diagnostics. With over 1900 experts in 30 offices worldwide, Precision offers novel clinical trial designs, industry-leading operational and medical experts and advanced biomarker solutions for pharm and biotech innovators.